| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.04 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.04 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |